Professor and Vice-Chair for Research, Department of Medicine (Cardiology), NYU Langone Health
Joined April 2013
- Tweets292
- Following222
- Followers1.7K
- Likes936
Great to see you and catch up. You’ve built a fantastic cardio-oncology/cardio-immunology program @UCSFCardiology - wish I could have convinced you to join us @nyulangone !!
Back @nyulangone (first talk since 2020, when exploring a position here set me on a path 2 @UCSFCardiology) Special to reconnect w/ @glennfishman, an extraordinary physician-scientist & leader who helped build NYU Cardiology into remarkable program over 25 years. Quite a legacy!
Gratifying to see how @PlateletDoc’s research program has matured and expanded over the years - it looks like translation into improved risk prediction and precision therapy for patients is around the corner.
At Med #GrandRounds @nyugrossman today, Jeffrey S. Berger, MD, (@PlateletDoc) Charles Aden Poindexter Associate Professor of Medicine, Associate Professor of Surgery, and Director of the Center for the Prevention of Cardiovascular Disease, delivered an outstanding talk on the expanding role of platelets in cardiovascular and inflammatory disease. Dr. Berger explored how platelets contribute not only to thrombosis, but also to atherogenesis, thromboinflammation, and emerging precision approaches to cardiovascular risk assessment and antiplatelet therapy
Key Takeaways:
▶️Platelets have multifaceted roles that extend beyond blood clotting into inflammation and atherosclerosis
▶️Platelets contribute to atherogenesis and may help drive vascular inflammation
▶️Thrombosis and thromboinflammation are related but distinct processes with important therapeutic implications
▶️Platelet biosignatures and platelet-omics may help identify cardiovascular risk more precisely
▶️Precision antiplatelet selection may become possible through platelet-guided approaches
▶️Targeting platelets may represent a strategy to reduce atherosclerosis progression
#MedEd #MedTwitter #GrandRounds #Cardiology #Platelets #CardiovascularDisease #Thromboinflammation #PrecisionMedicine #Atherosclerosis #AntiplateletTherapy
Well deserved recognition for my friend and colleague @LPhillipsMD. Along with @SVRaoMD, the @NYULH_DeptofMed Division of Cardiology is in the best of hands.
Congratulations to Lawrence Phillips, MD (@LPhillipsMD) who has been appointed Deputy Director of the Leon H. Charney Division of Cardiology.
#Exceptionalism #Leadership #FacultyAchievement #Cardiology
Handing over the @nyulangone Division of Cardiology to @SVRaoMD in pretty good shape! Thankful for great colleagues who still believe in and support the tripartite mission of academic medicine - even in these most challenging of times.
This was a great first day of medical school - totally innovative and engaging. Sitting quietly in the back of the lecture hall - I couldn’t help but admire what was transpiring in real time!
Thank you for the opportunity @TylerWebster! @nyugrossman first year med students had very sharp questions!
Thanks to @glennfishman and @SVRaoMD for providing such a collaborative environment.
Well done Louai. Delighted to see this recognition of your accomplishments.
Congratulations to Louai Razzouk, MD, MPH, on his greatly deserved promotion to Associate Professor of Medicine. “Heart disease is a chronic condition, and over time I get to know my patients well. This relationship helps me tailor medical treatments to meet each person’s specific medical and lifestyle needs. When they realize that they have a doctor and a medical team who will advocate for their best interests, it helps put them at ease.” —Dr. Razzouk
#Exceptionalism #FacultyAchievement #InterventionalCardiology #Cardiology
@LouaiRazzouk
@NYUCVDPrevent
It's been a good run! Stepping down as Division Director after 25 years. I've been blessed with the best colleagues and trainees. The programs we have created are exceptional and the collegiality has been nothing short of extraordinary. Good luck to @SVRaoMD
Glenn Fishman retweeted
Amazing grand rounds tying together environmental risk, genomics, and proteomics by the inimitable Jonathan Newman for the Sedlis Memorial Lecture @nyulangone @nyugrossman
yes - we arranged a watch party in Central Park for the overflow crowd! Thanks for visiting with us @ChiadiNdumele - it was a fantastic lecture. Much of the progress in the field can be traced back work from you and your colleagues (including some now here @nyulangone).
🤖 Made with AI
Dr Howard Weintraub was a beloved clinician, educator and clinical investigator. He co-founded our @NYUCVDPrevent Center at @nyulangone and promoted intense risk factor modification before it seemed obvious. He will be dearly missed.
Dr. Eugene Braunwald defined the modern era of cardiovascular medicine. An alum of NYU and our School of Medicine (the only one to admit Jewish students), Dr. Braunwald endowed an Assistant Professorship in our Division of Cardiology to support rising star clinician-investigators
Supporting the fight against women’s heart disease at the annual New York City American Heart Association Go Red for Women Celebration
Terrific talk today demonstrating the power of multi-dimensional profiling to identify new therapeutics for atherosclerotic vascular disease.
At Med #GrandRounds @nyugrossman today, Chiara Giannarelli, MD, PhD, Associate Professor of Medicine in the Leon H. Charney Division of Cardiology, delivered an enlightening talk on using multiomics for drug repurposing. She highlighted how deep immune phenotyping and multiomics of human atherosclerotic plaques can uncover disease-driving pathways and systematically match them to existing drugs with anti-inflammatory and anti-atherosclerotic potential.
Key Takeaways:
▶️Deep single-cell and multiomics profiling can reveal the precise immune mechanisms driving human atherosclerosis.
▶️T cells dominate the immune landscape of human atherosclerotic plaques, with distinct activated phenotypes compared with blood.
▶️Single-cell–driven drug repurposing can match inflammatory gene/protein signatures in atherosclerosis to existing compounds, accelerating therapeutic discovery.
▶️Saracatinib reduced plaque inflammation and macrophage content in preclinical models
▶️Deep phenotyping of atherosclerosis as a path towards precision medicine
#HealthcareInnovation #Atherosclerosis #Multiomics #SingleCell #CardiovascularResearch #DrugRepurposing #PrecisionMedicine @ChiaraGiannare1
Some thoughts on finding the best heart care, out today in @USNewsHealth. Look for quality outcomes, high volumes, access to clinical trials and a tightly integrated network of providers. health.usnews.com/health-car… @nyugrossman @nyulangone @NYULH_DeptofMed @NYUCVDPrevent
Fantastic team at @nyulangone supporting women who are affected by cardiovascular disease. Thanks for everything you do each and every day!
NYU Langone Cardiology showed up in full force today, including our incredible practice staff, proudly wearing red to shine a light on heart disease, the #1 killer of women.
Learn more about women's heart health⤵️
bit.ly/46ddHUr
#HeartMonth #GoRedForWomen #WEARRED2026
Congratulations to the entire team and especially to your leadership as medical director of the VAD Program @nyulangone.
A proud moment for the entire team @nyulangone: the first implant of the #BrioVAD system is now complete as part of the #INNOVATEtrial.
This milestone is about the patients who inspire this work as well as the clinicians, researchers, and engineers who push innovation into a meaningful reality. Huge congratulations and thank you to everyone who helped make this possible. Onward and upward!
#HeartFailure #ClinicalResearch #MedTech #Innovation #cardiotwitter #MedTwitter
18
3,823
Take a look at our new review on "The cardiac conduction system: development, function and therapeutic targets" just out in Nature Reviews Cardiol. at rdcu.be/eXeDW. Lots of exciting new advances in the field from so many great labs.
